Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)

15.69 +0.33 (+2.15%) At close: 03:04PM CST

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

No. 238 Tianshan Street
High-tech Industrial Development Zone
Shijiazhuang 050035
China
86 311 8590 1712
https://www.yiling.cn

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 13,958

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Xiang Jun Wu	Chairman & GM	N/A	N/A	1975
Mr. Chen Guang Li	CFO & Director	N/A	N/A	1973
Ms. Wei Wang	Deputy GM & Director of Administrative Center	N/A	N/A	1970
Mr. Wei Dong Xu	Executive Deputy Director of the Human Resources Center & Director	N/A	N/A	1968
Ms. Rui Wu	Secretary of the Board & Non-Independent Director	N/A	N/A	1980
Ms. Qiu Lian Zhang	Deputy GM & Non-Independent Director	N/A	N/A	1970
Mr. Xiaolin Zhou	Deputy GM & Director of the Supply Center	N/A	N/A	1970

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Corporate governance

Shijiazhuang Yiling Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.